About: Dyne Therapeutics, Inc., a clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscular diseases in the United States. The company is developing a portfolio of muscle disease therapeutics, including programs in myotonic dystrophy type 1; duchenne muscular dystrophy; facioscapulohumeral dystrophy; and Pompe disease, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. Dyne Therapeutics, Inc. was incorporated in 2017 and is headquartered in Waltham, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Latest price: $17.04 (+0.35%)
DYN NASDAQ Dyne Therapeutics Inc
Dyne Therapeutics Inc share price
Atividade de preço de DYN
Último preço
$ 17,040
Variação (24h)
0,06 USD (0,35%)
Volume
1.43M
Volume (média 4 sem.)
-
Abertura
$ 17,20
Variação do dia
$ 16,75 - $ 17,59
Fechamento anterior
$ 16,98
Último negócio
29 Oct, 8:00 pm GMT+0
Atrasado
29 Oct, 8:00 pm GMT+0
DYN price performance
Atrasado
29 Oct, 8:00 pm GMT+0
quote.marketSignals